Product documentation
Ask about batch-specific certificates of analysis, test methods and available documentation for Cabergoline (20ct). Confirm that any report matches the lot you intend to order — what a certificate of analysis reports covers which field answers which question.
Request documentation for Cabergoline (20ct)Cabergoline (20ct)
Cabergoline 0.25mg, 20 tablets - a long-acting dopamine D2 receptor agonist studied for prolactin regulation research.
Research Use Only:This compound is intended exclusively for in vitro laboratory research applications. Not for human or veterinary consumption.
Cabergoline (20ct) research overview
Cabergoline is an ergoline-derived dopamine receptor agonist with high affinity for the D2 receptor, supplied as 20 tablets at 0.25mg each.
Its research value comes from duration. Dopamine tonically inhibits prolactin release from pituitary lactotroph cells, and most D2 agonists demonstrate that relationship over a matter of hours. Cabergoline's half-life is measured in days, which allows a model to hold D2 receptor occupancy relatively constant across a protocol rather than chasing a decaying curve. Published work uses it in prolactin regulation studies, lactotroph physiology, and in characterising the pituitary end of dopaminergic signaling. A separate literature examines D2 agonism in nigrostriatal models and the receptor pharmacology of the ergoline class more generally, including affinity at serotonergic receptors that the class also engages.
This 20-tablet count is the smaller of the packaging options and suits shorter or pilot protocols. Cabergoline sits in the endocrine support group alongside compounds acting on estrogen synthesis and estrogen receptors, but its target is entirely separate - dopaminergic rather than steroidal - so it is a mechanistic complement rather than an alternative. Store tablets at room temperature in the sealed container. For laboratory research only. Not a prescription medicine and not for human or veterinary use.
- Dopamine D2 receptor agonist research
- Prolactin regulation and lactotroph studies
- Sustained receptor occupancy protocols
- Ergoline class receptor pharmacology
- Nigrostriatal dopaminergic models
Cabergoline (20ct) specifications
| Form | Oral Tablets |
|---|---|
| Count | 20 tablets |
| Storage | Room temperature, sealed container |
| Strength | 0.25mg per tablet |
| Mechanism | Long-acting dopamine D2 receptor agonist |
| Research Use | Laboratory research only - not a prescription medicine |
| Reported Purity | 99% |
Questions about this listing
- What form does Cabergoline (20ct) come in?
Oral Tablets The size options listed on this page — 0.25mg / 20 tablets — are what is available, and the vial labelling shown in the product images above is the reference for what a vial contains.
- How should Cabergoline (20ct) be stored?
Room temperature, sealed container. Storage requirements differ across the catalog — some listings are refrigerated, others held at -20°C, others at room temperature — so read this row rather than assuming from a neighbouring product.
- What does the 99% figure on this listing mean?
It is the purity reported for this material. It is a reported value rather than one Savage Labs has independently verified for the lot you receive, and it does not describe net peptide content. How peptide purity is reported and net peptide content cover what the number does and does not tell you.
- What documentation is available for Cabergoline (20ct)?
Batch-specific certificates of analysis and test methods on request. Confirm that any report matches the lot you intend to order — reading a peptide certificate of analysis covers which field answers which question. Ask about documentation for this listing, or see the full FAQ for ordering, shipping and returns.
- What else is grouped with Cabergoline (20ct)?
It is catalogued under PCT & Support, where the category page describes what separates the compounds in the group.
Ordering, payment, shipping and returns are answered on the full FAQ.
References
The published work the description above draws on. These are indexed records, not Savage Labs documentation, and none of them establishes a use for Cabergoline (20ct) in people or animals. For records covering the material itself, ask about batch documentation.
- Cabergoline — Expert Opin Pharmacother (2000) · PMID 11249538
- Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas — Pharmacogenomics J (2008) · PMID 18332900
